Departures.......yet?

Quote












anonymous said:
the compensation isn’t bad, more than the other Syneos contract base salaries. Most are doing 75-85 base plus commission which target is usually 6500 a quarter. Coverage isn’t great but if you are in a bigger market territory it helps
Click to expand...

many reps are making very little bonus because coverage sucks due to the drug being overpriced
 
























anonymous said:
unfortunately, this site limits the amount of characters in a post to 5000. So to keep it short and sweet...The drug is shite!! Absolute SHITE!! Flush this turd!!!!
Click to expand...

Well that response just verified that you are not someone internal. If you were, you would know the drug is fine. A product with unlimited potential if it were in competent hands. Unfortunately, current leadership is clueless.
 












anonymous said:
Well that response just verified that you are not someone internal. If you were, you would know the drug is fine. A product with unlimited potential if it were in competent hands. Unfortunately, current leadership is clueless.
Click to expand...
It’s not the elementary level leadership, or the horrible coverage. Look at the data..the drug is trash.
 






anonymous said:
Anyone know of anyone resigning from this clusterf@$% now that Q1 bonus is in hand? F, L & D are very lucky the job market is tight right now.
Click to expand...

On the last monthly call, we still don’t know what’s going on. My thought is they’re not going to hire us a Clarus for awhile if at all. They didn’t renew their business development contract with Syneos 6 months ago, this is not for the sales force. I’m speculating a few options.
1. Dr Dudley’s exit strategy might be to sell the company and take the $$$. He’s already enjoying the fruits of his labor on the beach while despite all of the reps efforts, we still cant get the Drs to switch patients.
2. Clarus might be shopping around for another sales force like with iQuivia. They’re always so disappointed with our performance. Maybe consider the fact that most Drs don’t give a shit about a pill vs a shot. Perhaps the idea sounded good and preliminary market research was positive, but Drs & patients don’t believe oral is a benefit and offices don’t want to do the prior authorizations
3. They keep the Syneos reps and keep beating them until they perform to meet their financial forecasts. I think I could work 23 hours a day and it would not increase sales results. Seriously, the harder I work=less sales, the less I work = or more sales. Doesn’t make sense
Not being pessimistic, just real
 












anonymous said:
Out of curiosity, would you mind sharing at what percent bonus was paid out? Not really interested in amount, but percentage on target. This place seemed like a dumpster fire containing a nuclear bomb.
Click to expand...
I got my highest bonus, $6000. Q2 last year 0! I guess it’s ALL my fault that no one prescribed it.
 






anonymous said:
On the last monthly call, we still don’t know what’s going on. My thought is they’re not going to hire us a Clarus for awhile if at all. They didn’t renew their business development contract with Syneos 6 months ago, this is not for the sales force. I’m speculating a few options.
1. Dr Dudley’s exit strategy might be to sell the company and take the $$$. He’s already enjoying the fruits of his labor on the beach while despite all of the reps efforts, we still cant get the Drs to switch patients.
2. Clarus might be shopping around for another sales force like with iQuivia. They’re always so disappointed with our performance. Maybe consider the fact that most Drs don’t give a shit about a pill vs a shot. Perhaps the idea sounded good and preliminary market research was positive, but Drs & patients don’t believe oral is a benefit and offices don’t want to do the prior authorizations
3. They keep the Syneos reps and keep beating them until they perform to meet their financial forecasts. I think I could work 23 hours a day and it would not increase sales results. Seriously, the harder I work=less sales, the less I work = or more sales. Doesn’t make sense
Not being pessimistic, just real
Click to expand...

The problem is simply that the price is too high. You can’t expect docs to switch to a new drug that cost 10-20 times more than other treatments with no added benefits. And PA’s are tough because payers don’t want to pay the premium price either. The only option is to cut price.
 






anonymous said:
The problem is simply that the price is too high. You can’t expect docs to switch to a new drug that cost 10-20 times more than other treatments with no added benefits. And PA’s are tough because payers don’t want to pay the premium price either. The only option is to cut price.
Click to expand...
We could give it away for free. Still wouldn’t change the fact that this dookie stinks.
 






anonymous said:
On the last monthly call, we still don’t know what’s going on. My thought is they’re not going to hire us a Clarus for awhile if at all. They didn’t renew their business development contract with Syneos 6 months ago, this is not for the sales force. I’m speculating a few options.
1. Dr Dudley’s exit strategy might be to sell the company and take the $$$. He’s already enjoying the fruits of his labor on the beach while despite all of the reps efforts, we still cant get the Drs to switch patients.
2. Clarus might be shopping around for another sales force like with iQuivia. They’re always so disappointed with our performance. Maybe consider the fact that most Drs don’t give a shit about a pill vs a shot. Perhaps the idea sounded good and preliminary market research was positive, but Drs & patients don’t believe oral is a benefit and offices don’t want to do the prior authorizations
3. They keep the Syneos reps and keep beating them until they perform to meet their financial forecasts. I think I could work 23 hours a day and it would not increase sales results. Seriously, the harder I work=less sales, the less I work = or more sales. Doesn’t make sense
Not being pessimistic, just real
Click to expand...

Need to dump the ones that can’t sell and reward the ones that do. Frank is an imbecile.
 






I’m surprised it took this long, but it’s clear that there has been and continues to be a mass exodus from this self-induced shit show of a company. I used to feel sorry for Bob D., but he got what he deserved by letting greed alter his judgment when setting the price of the drug, and then trying to market it on the cheap.
 






Get out as soon as you can. Everyone I know is looking and extremely unhappy. Sinking ship due to upper managements inability to properly price and market a branded drug in a highly driven generic space. Managed care coverage is awful and not near where they claim it to be. Priced greedily and providers won’t rx due to that and the PA process that leads to a denial. If this product would have been launched in the proper hands it would have been successful but bringing it to market like the old Androgel days was moronic at best.
 


















Those morons have no idea what they’re doing and clearly no idea what a ‘blockbuster’ drug is. Jatenzo is clearly not.. it’s a hard sell! A true blockbuster sells on its own where there’s scripts being written out the arse. Blockbuster drugs have scripts waiting at the pharmacy before drug is even launched. None of these happened w Jatenzo. Hardly any Drs were even excited when reps first launched. Coverage 50% at best. Failing launch n sales numbers.
 






Top Bottom
Back
Quote